Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,232 | 111,184 | 127,965 | 169,912 | 229,520 |
| Receivables | 18,601 | 7,418 | N/A | 16,857 | 7,559 |
| Inventories | 52,997 | 41,973 | N/A | 18,525 | 5,340 |
| Other current assets | 0 | 0 | 39,396 | 0 | 0 |
| TOTAL | $149,265 | $165,181 | $175,410 | $214,394 | $251,238 |
| Non-Current Assets | |||||
| PPE Net | 17,794 | 19,115 | 17,614 | 23,566 | 24,026 |
| Investments And Advances | 0 | 1,401 | 1,401 | 1,401 | 1,401 |
| Other Non-Current Assets | 154,672 | 155,565 | 164,175 | 128,338 | 129,722 |
| TOTAL | $172,466 | $176,081 | $183,190 | $153,305 | $155,149 |
| Total Assets | $321,731 | $341,262 | $358,600 | $367,699 | $406,387 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,809 | 5,219 | 3,641 | 8,958 | 12,922 |
| Accrued Expenses | 86,356 | 76,317 | 22,509 | 54,158 | 55,878 |
| TOTAL | $108,282 | $98,478 | $98,659 | $79,225 | $77,898 |
| Non-Current Liabilities | |||||
| Long Term Debt | 102,494 | 102,009 | 101,544 | 101,135 | 100,742 |
| Deferred Revenues | 7,922 | 8,109 | N/A | 9,829 | 3,628 |
| Other Non-Current Liabilities | 102,665 | 105,149 | 203,253 | 107,398 | 110,206 |
| TOTAL | $300,523 | $302,522 | $304,797 | $303,597 | $305,875 |
| Total Liabilities | $408,805 | $401,000 | $403,456 | $382,822 | $383,773 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,587 | 7,572 | 7,550 | 6,463 | 6,410 |
| Common Shares | 152 | 151 | 135 | 129 | 128 |
| Retained earnings | -1,051,238 | -1,018,368 | -978,235 | -936,987 | -889,133 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -1 |
| TOTAL | $-87,074 | $-59,738 | $-44,856 | $-15,123 | $22,614 |
| Total Liabilities And Equity | $321,731 | $341,262 | $358,600 | $367,699 | $406,387 |